Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics
- PMID: 16835587
- DOI: 10.1038/sj.ejhg.5201695
Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics
Similar articles
-
Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.Eur J Neurol. 2007 Nov;14(11):e6. doi: 10.1111/j.1468-1331.2007.01933.x. Eur J Neurol. 2007. PMID: 17956439 No abstract available.
-
Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.Ann Neurol. 2005 Jun;57(6):933-4. doi: 10.1002/ana.20510. Ann Neurol. 2005. PMID: 15929036 No abstract available.
-
Genetics of Parkinson's disease: LRRK2 on the rise.Brain. 2005 Dec;128(Pt 12):2760-2. doi: 10.1093/brain/awh676. Brain. 2005. PMID: 16311269 No abstract available.
-
[What can we learn from genes responsible for familial forms of Parkinson's disease?].Bull Acad Natl Med. 2006 Feb;190(2):485-96; discussion 497-8. Bull Acad Natl Med. 2006. PMID: 17001874 Review. French.
-
Clinical genetics of Parkinson's disease and related disorders.Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Parkinsonism Relat Disord. 2007. PMID: 18267241 Review.
Cited by
-
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.Nat Commun. 2023 Jun 20;14(1):3651. doi: 10.1038/s41467-023-39038-8. Nat Commun. 2023. PMID: 37339976 Free PMC article.
-
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.J Neurosci. 2009 Nov 4;29(44):13971-80. doi: 10.1523/JNEUROSCI.3799-09.2009. J Neurosci. 2009. PMID: 19890007 Free PMC article.
-
Parkinson's disease: Exit toxins, enter genetics.Prog Neurobiol. 2010 Feb 9;90(2):146-56. doi: 10.1016/j.pneurobio.2009.11.001. Epub 2009 Nov 17. Prog Neurobiol. 2010. PMID: 19925845 Free PMC article. Review.
-
Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949. J Neurosci Res. 2009. PMID: 19025767 Free PMC article. Review.
-
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease.Elife. 2021 Sep 30;10:e73062. doi: 10.7554/eLife.73062. Elife. 2021. PMID: 34590578 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical